Last $6.20 USD
Change Today -0.01 / -0.16%
Volume 850.0
EVAR On Other Exchanges
As of 8:10 PM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

lombard medical inc (EVAR) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/25/14 - $11.34
52 Week Low
07/18/14 - $5.72
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for LOMBARD MEDICAL INC (EVAR)

Related News

No related news articles were found.

lombard medical inc (EVAR) Related Businessweek News

No Related Businessweek News Found

lombard medical inc (EVAR) Details

Lombard Medical, Inc., a medical technology company, develops, manufactures, and markets endovascular stent-grafts for the repair of aortic aneurysms in the United States, the United Kingdom, Germany, and internationally. The company’s principal product is Aorfix, which is an endovascular stent-graft for the treatment of an abdominal aortic aneurysm with angulation at the neck of the aneurysm of up to 90 degrees. It is also developing stent-graft system to treat thoracic aortic aneurysms. Lombard Medical sells its products directly through its direct sales force and third-party distributors. The company was founded in 2000 and is based in Didcot, United Kingdom.

121 Employees
Last Reported Date: 04/25/14
Founded in 2000

lombard medical inc (EVAR) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

lombard medical inc (EVAR) Key Developments

Lombard Medical, Inc. Presents at Jefferies 2014 Global Healthcare Conference, Jun-05-2014 11:00 AM

Lombard Medical, Inc. Presents at Jefferies 2014 Global Healthcare Conference, Jun-05-2014 11:00 AM. Venue: Grand Hyatt, New York, New York, United States. Speakers: Simon Hubbert, Chief Executive Officer and Director.

Lombard Medical, Inc. Announces Financial Results for the First Quarter Ended March 31, 2014

Lombard Medical, Inc. announced financial results for the first quarter ended March 31, 2014. For the quarter, total sales grew 64% to $2.0 million compared with $1.3 million in the first quarter of 2013. The lower total growth figure reflected the divestment of the company's OEM business in December 2013. Sales from this business were $0.3 million in the first quarter of 2013. Net loss was $6.9 million, compared to $3.0 million in the first quarter of 2013. The increased loss was principally due to on-going investments in a US-based operation, commercial infrastructure, direct sales force and training activities.

Lombard Medical, Inc.(NasdaqGM:EVAR) added to NASDAQ Composite Index

Lombard Medical, Inc. will be added to the NASDAQ Composite Index.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EVAR:US $6.20 USD -0.01

EVAR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Boston Scientific Corp $13.02 USD +0.17
CR Bard Inc $145.83 USD +2.01
Endologix Inc $14.50 USD -0.11
Medtronic Inc $63.37 USD +0.66
TriVascular Technologies Inc $14.67 USD -0.33
View Industry Companies

Industry Analysis


Industry Average

Valuation EVAR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 39.9x
Price/Book 5.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 8.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LOMBARD MEDICAL INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at